Literature DB >> 30327925

Late-stage myeloma invades kidney without significant effect on renal function: findings from 53 autopsies in a single institute.

Junichiro Takano1, Sohtaro Mine1, Makoto Mochizuki2, Noriko Tanaka3, Shotaro Hagiwara4,5.   

Abstract

Renal manifestations of multiple myeloma (MM) including cast nephropathy, amyloidosis, and renal calcification have been widely recognized. However, the severity of histopathological findings has not been addressed so far, and the clinical significance of these pathological findings is unclear. We sought to clarify the relationship between the severity of renal pathology and clinical characteristics. We analyzed 53 autopsies performed on patients who died from MM. The kidneys were evaluated using light microscopy, and the severity of pathological findings was recorded. The most common renal lesion was cast nephropathy (n = 27). Other findings included amyloidosis (n = 10), renal calcification (n = 5), microbial infection (n = 4), and MM infiltration (n = 17). The incidence of MM infiltration was substantially higher than previously reported. Renal MM infiltration was detected even when bone marrow plasmacytosis was limited. However, a significantly higher degree of renal MM infiltration was observed when MM cells invaded the liver. No correlation was observed between serum creatinine levels and degree of MM infiltration, but these tended to be elevated when cast nephropathy was severe. These findings may provide clues to understand both renal injury and extramedullary diseases in patients with MM.

Entities:  

Keywords:  Cast nephropathy; Extramedullary disease; Multiple myeloma; Renal infiltration by myeloma; Renal injury

Mesh:

Substances:

Year:  2018        PMID: 30327925     DOI: 10.1007/s12185-018-2546-8

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  25 in total

Review 1.  Mechanisms of disease: monoclonal immunoglobulin deposition. Amyloidosis, light chain deposition disease, and light and heavy chain deposition disease.

Authors:  J Buxbaum
Journal:  Hematol Oncol Clin North Am       Date:  1992-04       Impact factor: 3.722

2.  Renal Lesions Associated with Multiple Myeloma.

Authors:  E T Bell
Journal:  Am J Pathol       Date:  1933-07       Impact factor: 4.307

3.  Whole-body (18)F-FDG PET identifies high-risk myeloma.

Authors:  Brian G M Durie; Alan D Waxman; Allesandro D'Agnolo; Cindy M Williams
Journal:  J Nucl Med       Date:  2002-11       Impact factor: 10.057

4.  Different patterns of relapse after autologous peripheral blood stem cell transplantation in multiple myeloma: clinical results of 280 cases from the Spanish Registry.

Authors:  Adrián Alegre; Asunción Granda; Carmen Martínez-Chamorro; Joaquín Díaz-Mediavilla; Rafael Martínez; José García-Laraña; Juan-José Lahuerta; Anna Sureda; Joan Bladé; Javier de la Rubia; José Maria Fernández-Rañada; Jesús San Miguel
Journal:  Haematologica       Date:  2002-06       Impact factor: 9.941

5.  The role of anatomic and functional staging in myeloma: description of Durie/Salmon plus staging system.

Authors:  Brian G M Durie
Journal:  Eur J Cancer       Date:  2006-06-13       Impact factor: 9.162

Review 6.  Renal pathologic spectrum in an autopsy series of patients with plasma cell dyscrasia.

Authors:  Guillermo A Herrera; Lija Joseph; Xin Gu; Aubrey Hough; Bart Barlogie
Journal:  Arch Pathol Lab Med       Date:  2004-08       Impact factor: 5.534

7.  Incidence, presenting features and outcome of extramedullary disease in multiple myeloma: a longitudinal study on 1003 consecutive patients.

Authors:  M Varettoni; A Corso; G Pica; S Mangiacavalli; C Pascutto; M Lazzarino
Journal:  Ann Oncol       Date:  2009-07-24       Impact factor: 32.976

Review 8.  Pathogenesis and treatment of renal failure in multiple myeloma.

Authors:  M A Dimopoulos; E Kastritis; L Rosinol; J Bladé; H Ludwig
Journal:  Leukemia       Date:  2008-06-05       Impact factor: 11.528

9.  Nephrotoxic potential of Bence Jones proteins.

Authors:  A Solomon; D T Weiss; A A Kattine
Journal:  N Engl J Med       Date:  1991-06-27       Impact factor: 91.245

10.  The impact of extramedullary disease at presentation on the outcome of myeloma.

Authors:  Ping Wu; Faith E Davies; Kevin Boyd; Karen Thomas; Sharon Dines; Radovan M Saso; Mike N Potter; Mark E Ethell; Bronwen E Shaw; Gareth J Morgan
Journal:  Leuk Lymphoma       Date:  2009-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.